NTRK1 and cancer: Potential molecular proliferative signaling targets for anti-cancer activity of silibinin include the receptor tyrosine kinase, STAT, androgen receptor and NF-κB pathways [20], however, anti-cancer activity of SM is beyond the scope of the present review.